West Palm Beach, Florida 33401

  • Type 1 Diabetes Mellitus


Analyze the Medtronic 670g pump on glycemic control

Study summary:

An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance


Inclusion Criteria: - age 18 or older - Documented History of Type 1 Diabetes Mellitus - 3 months continuous use of the Medtronic 670g pump system - given written informed consent Exclusion Criteria: - Less than 3 months use of the Medtronic 670g pump system - Taking any other medication, other than the insulin used in the Medtronic 670g pump, to manage their diabetes - having medical conditions or taking medications that would preclude subject involvement or affect the outcomes being measured, in the opinion of the Investigator



Primary Contact:

Principal Investigator
Barry S Horowitz, MD
Metabolic Research Institute, Inc.

Paula M Dear
Phone: 561-802-3060 ext. 8045
Email: pdear@metabolic-institute.com

Backup Contact:

Email: adonadio@metabolic-institute.com
Adriana Donadio
Phone: 561-802-3060 ext. 8033

Location Contact:

West Palm Beach, Florida 33401
United States

Paula Dear
Phone: 561-802-3060
Email: pdear@metabolic-institute.com

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 03, 2023

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.